Aerovance inhales $38M for asthma drugs
Aerovance, developer of asthma medications, just brought in $38 million in a post-recapitalized third round of funding to push its lead drug candidate through a second phase of clinical trials. The company has already received $20 million, with the option of claiming the remaining $18… Continue Reading
Pearl Therapeutics gathers $8M to treat breathing disorders
Pearl Therapeutics, a Redwood City, Calif.-based developer of inhaled drugs to treat respiratory diseases like COPD and asthma, just landed $8 million in venture debt from Oxford Finance and Silicon Valley Bank to expand its product line.
The company licensed particle-based technology from San Carlos, Calif.-based… Continue Reading
Pelikan closes $25M for handheld diagnostics
Pelikan Technologies, maker of medical devices for diagnosing and monitoring diabetes, just brought in $25 million from undiclosed investors, reports VentureWire. Based in Palo Alto, Calif., the company spun out of Agilent Technologies in 2001 with the launch of its Pelikan Sun line, an electronic… Continue Reading
CeNeRx takes $15M to fight depression
CeNeRx BioPharma recently raised $15 million in a second round of funding contributed by Aisling Capital, L Capital Partners and Pappas Ventures. The Cary, N.C. company specializes in treatments for central nervous system disorders. It plans to use the money to push its lead drug… Continue Reading
Pelikan Tech to push “finger friendly” diabetes testing
One of the constant but unavoidable challenges in trying to control diabetes is the frequent need to test blood-sugar levels by sticking a needle into a fingertip — a step that tells diabetics when they need a snack (to raise blood glucose) or a shot… Continue Reading
Life sciences briefing: Monday, Oct. 15, 2007
Featured companies: Biolipox, Cellpoint Diagnostics, Corum Medical, MediKeeper, Mendel Biotechnology, NanoMed, Orexo, Rules-Based Medicine, Tengion
UPDATED: Expanded the Tengion item, and that’s about it.
Tengion raises $33M for bladder regrowth — Tengion, a Norriton, Pa., biotech focused on regenerating diseased or damaged organs, raised $33 million in a third… Continue Reading
Life sciences briefing: Tuesday, Aug. 28, 2007
Featured companies: ProNAi, Rubicor
ProNAi raises $2M for IV cancer drugs — ProNAi, a Kalamazoo, Mich., biotech focused on intravenous cancer drugs, raised $2 million toward a $4 million bridge round, VentureWire reports (subscription required). The company aims to raise a $25 million second round later tihs… Continue Reading